Galderma Group AG Logo

Galderma Group AG (GDERF)

OTC

Currency in USD
222.30
+17.29 (+8.43%)

Closed

Aug 21, 2026

Day's Range

221.55
222.30

52 wk Range

165.00
248.46

Overview - GDERF - Galderma Group AG

Key Statistics

Valuation

Enterprise Value

53.71B

P/E (Trailing)

‪66.16‬

Price / Sales (TTM)

‪8.75‬

Price / Book

‪6.31‬

EV / EBITDA

‪38.75‬

Profitability

Profit Margin

‪14.57%‬

Operating Margin

‪20.23%‬

Return on Assets

‪5.35%‬

Return on Equity

‪10.82%‬

Ownership

Shares Outstanding

234.56M

Float

131.26M

Held by Insiders

‪21.02%‬

Held by Institutions

‪48.21%‬

Price stats

Beta

‪-0.09‬

50-Day Avg

‪217.04‬

200-Day Avg

‪202.76‬

Dividends

Payout Ratio

‪12.11%‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 17, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - GDERF - Galderma Group AG

Peers - GDERF - Galderma Group AG

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.

Profile Summary - GDERF - Galderma Group AG

About

Galderma Group AG is a leading global dermatology company headquartered in Zug, Switzerland, founded in 1981. The company operates across three core business segments: injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio encompasses flagship brands including Dysport and Azzalure…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees7.67K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.